Echinacea biotechnology: Challenges and opportunities |
| |
| Authors: | Bilal Haider Abbasi Praveen K. Saxena Susan J. Murch Chun-Zhao Liu |
| |
| Affiliation: | (1) National Key Laboratory of Biochemical Engineering, Institute of Process Engineering, Chinese Academy of Sciences, Beijing, 100080, People’s Republic of China;(2) Department of Plant Agriculture, University of Guelph, Guelph, ON, N1G 2W1, Canada;(3) Chemistry, I. K. Barber School of Arts and Sciences, University of British Columbia, Okanagan, Kelowna, BC, V1V 1V7, Canada;(4) Arkansas Biosciences Institute, Arkansas State University, Jonesboro, AR 72467, USA;(5) Graduate School of the Chinese Academy of Sciences, Beijing, 100049, People’s Republic of China |
| |
| Abstract: | Echinacea, better known as purple coneflower, has received a global attention because of its increasing medicinal value. There is enormous potential for the discovery of new medicinal compounds in this species and an immediate need for techniques to facilitate the production of high quality, chemically consistent plant material for drug development and clinical trials. In vitro tissue culture of Echinacea can play a vital role in the development of novel germplasm, rapid multiplication, and genetic modifications for an enhanced phytochemical production. Recent establishment of liquid culture techniques, large-scale bioreactors, and Agrobacterium-mediated transformation are changing the production parameters of the Echinacea species. This review provides an overview of the recent developments in in vitro technologies and challenges that remain in the Echinacea biotechnology. |
| |
| Keywords: | Echinacea Plant regeneration Somatic embryogenesis Agrobacterium-mediated transformation Plant growth regulators Phytochemicals |
| 本文献已被 SpringerLink 等数据库收录！ |
|
